Slideshow

Treatment for Antipsychotic-Induced Tardive Dyskinesia: New Insights

Author(s):

Brian Miller, MD, PhD, MPH

Tardive dyskinesia, an involuntary athetoid or choreiform movements, generally of the tongue, lower face and jaw, and extremities, is highly prevalent in patients with schizophrenia after long-term antipsychotic use. What about clozapine for TD?

Related Videos
emergency
schizophrenia
sc
schizophrenia
clozapine
brain
cognition
clock
clozapine
Related Content
Novel PDE10A Inhibitor for Acute Schizophrenia Exacerbation Presented at APA Annual Meeting
May 18th 2025

Novel PDE10A Inhibitor for Acute Schizophrenia Exacerbation Presented at APA Annual Meeting

Heidi Anne Duerr, MPH
Treating ‘Morally Objectionable’ Patients
September 27th 2021

Treating ‘Morally Objectionable’ Patients

James L. Knoll IV, MD
delirium
May 9th 2025

Antipsychotics and the QTc Interval During Delirium in the Intensive Care Unit: A Secondary Analysis of a Randomized Clinical Trial

Joshua Robak, MD Nishi Modi, MBBS Haley Schuster, MD Mark Mullen, MD Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP
More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle
May 11th 2021

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

Anita H. Clayton, MD
pills
April 30th 2025

April in Review: Updates on the Psychiatric Treatment Pipeline

Leah Kuntz
schizophrenia
April 22nd 2025

Cobenfy as Add-On Treatment for Schizophrenia Fails to Meet Primary Endpoint in Phase 3 ARISE Trial

Leah Kuntz
© 2025 MJH Life Sciences

All rights reserved.